Ozempic maker Novo Nordisk posts strong results but competition weighs
The group reported a net profit of 26.5 billion kroner ($4.1 billion), a 32 percent increase from the same period last year, while sales increased by 18 percent to 76 billion kroner.
The drug maker lowered its annual earnings outlook last week, causing its share price to continue its nearly year-long slide.
The company had already cut its forecast in May and announced the departure of its chief executive Lars Fruergaard Jorgensen.
'In May we mostly thought the bottom was reached,' Mikael Bak, director of the Danish shareholders' association, told AFP.
Bak said 'every is a bit surprised' that the situation has deteriorated.
'So now we don't want to see more disappointments, there are reasons to believe the business is healthy, the institution and the products good,' he said.
Novo Nordisk announced last week that it was promoting Maziar Mike Doustdar, its vice president for international operations, to succeed Jorgensen.
The popularity of Novo Nordisk's weight-loss treatments had once made it a darling of investors, boosting its share price and at one point making it Europe's most valuable company.
But it now faces growing competition from rival treatments made by US group Eli Lilly in United States.
A rule by the US Food and Drug Administration allowing pharmacies to create so-called 'compound' copycat versions of the drug, after high demand led to shortages, has also dented Novo Nordisk's earnings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Iraqi News
6 days ago
- Iraqi News
Accumulating bitcoin a risky digital rush by companies?
London – US President Donald Trump's media group and Tesla, the electric carmaker owned by tech billionaire Elon Musk, are among an increasing number of companies buying huge amounts of bitcoin. The aim? To diversify reserves, counter inflation and attract investors, analysts say. – Who also invests? – Companies frequently own bitcoin — the largest cryptocurrency by market capitalisation — to take part in sector activities such as 'mining', which refers to the process of validating transactions in exchange for digital tokens. Tesla has previously accepted payments in bitcoin, while Trump Media soon plans to offer crypto investment products. Other players who had core operations totally unrelated to cryptocurrency, such as Japanese hotel business MetaPlanet, have switched to buying bitcoin. US firm Strategy, initially a seller of software under the name MicroStrategy, holds more than three percent of all bitcoin tokens, or over 600,000. Its co-founder Michael Saylor 'created real value for its original set of investors' by offering the opportunity to invest in shares linked to cryptocurrencies, Andy Constan, chief executive of financial analysts Damped Spring Advisors, told AFP. This was five years ago when other financial products allowing investment in cryptocurrencies, without a need to directly own tokens, were not permitted. – Why invest? – Companies collect bitcoins 'to diversify' their cash flow and 'counter the effects of inflation', said Eric Benoist, a tech and data research expert for Natixis bank. Some struggling companies are riding the trend in a bid to 'restore their image' by 'backing themselves with an asset perceived as solid and one that appreciates over time', he added. Strategy's current focus is on accumulating bitcoin, simply to attract investors interested in the currency's potential. Bitcoin can also have a simple practical use, as in the case of the Coinbase exchange, which uses its own reserves as collateral for its users. – The risks? – Bitcoin's value has soared around ninefold in five years, fuelled recently by US regulatory changes under Trump, a strong backer of the crypto sector. However, the unit's volatility is four times greater than that of the main US stock index, the S&P 500, according to Campbell Harvey, a professor of finance at Duke University in the United States. Harvey warns against using a company's cash reserves, 'their safe haven', to buy crypto. Bitcoin's price, currently around $117,000, has in recent years been boosted by large holders of cryptocurrency, referred to as 'whales'. Harvey argues that in the case of 'major buyer' Strategy, liquidating all their 600,000 bitcoin tokens is no simple task owing to the high value. 'Assuming that you could liquidate all of those bitcoin at the market price is a heroic assumption,' he told AFP, adding such a deal would see the cryptocurrency's price plummet. Jack Mallers, chief executive and co-founder of bitcoin-focused company Twenty One Capital, said his business embraced the sector's volatility, adding the market would need to be flooded for the token's price to crash. – A bubble? – According to its own calculation, Strategy's stock is selling at about 70 percent above the value of its bitcoin reserves. The company — which did not answer AFP's request for comment — is growing thanks to bitcoin purchases, which in turn is attracting investors and pushing up its share price. But ultimately it will need to monetise these crypto assets, for example by linking them to financial products, for its business to be sustained. Should Strategy and other so-called 'bitcoin treasury funds' fail to do so, Benoist fears the crypto investment bubble will burst. He points out that the strategy of accumulation runs counter to the original philosophy of bitcoin, which was conceived in 2008 as a decentralised means of payment. Today, 'bitcoins end up in electronic safes that are left untouched', he said.
Iraqi News
07-08-2025
- Iraqi News
Higher US tariffs take effect on dozens of economies
Washington – Higher US tariffs came into effect for dozens of economies Thursday, drastically raising the stakes in President Donald Trump's wide-ranging efforts to reshape global trade. As an executive order signed last week by Trump took effect, US duties rose from 10 percent to levels between 15 percent and 41 percent for a list of trading partners. Many products from economies like the European Union, Japan and South Korea now face a 15-percent tariff, even with deals struck with Washington to avert steeper threatened levies. But others like India face a 25-percent duty — to be doubled in three weeks — while Syria, Myanmar and Laos face staggering levels at either 40 percent or 41 percent. The latest tariff wave of 'reciprocal' duties, aimed at addressing trade practices Washington deems unfair, broadens the measures Trump has imposed since returning to the presidency. But these higher tariffs do not apply to sector-specific imports that are separately targeted, such as steel, autos, pharmaceuticals and chips. Trump said Wednesday he planned a 100-percent tariff on semiconductors — though Taipei said chipmaking giant TSMC would be exempt as it has US factories. Even so, companies and industry groups warn that the new levies will severely hurt smaller American businesses. Economists caution that they could fuel inflation and weigh on growth in the longer haul. While some experts argue that the effects on prices will be one-off, others believe the jury is still out. With the dust settling on countries' tariff levels, at least for now, Georgetown University professor Marc Busch expects US businesses to pass along more of the bill to consumers. An earlier 90-day pause in these higher 'reciprocal' tariffs gave importers time to stock up, he said. But although the wait-and-see strategy led businesses to absorb more of the tariff burden initially, inventories are depleting and it is unlikely they will do this indefinitely, he told AFP. 'With back-to-school shopping just weeks away, this will matter politically,' said Busch, an international trade policy expert. – Devil in the details – The tariff order taking effect Thursday also leaves lingering questions for partners that have negotiated deals with Trump recently. Tokyo and Washington, for example, appear at odds over key details of their tariffs pact, such as when lower levies on Japanese cars will take place. Washington has yet to provide a date for reduced auto tariffs to take effect for Japan, the EU and South Korea. Generally, US auto imports now face a 25-percent duty under a sector-specific order. A White House official told AFP that Japan's 15-percent tariff stacks atop of existing duties, despite Tokyo's expectations of some concessions. Meanwhile, the EU continues to seek a carveout from tariffs for its key wine industry. In a recent industry letter addressed to Trump, the US Wine Trade Alliance and others urged the sector's exclusion from tariffs, saying: 'Wine sales account for up to 60 percent of gross margins of full-service restaurants.' – New fronts – Trump is also not letting up in his trade wars. He opened a new front Wednesday by doubling planned duties on Indian goods to 50 percent, citing New Delhi's continued purchase of Russian oil. But the additional 25-percent duty would take effect in three weeks. Trump's order for added India duties also threatened penalties on other countries that 'directly or indirectly' import Russian oil, a key revenue source for Moscow's war in Ukraine. Existing exemptions still apply, with pharmaceuticals and smartphones excluded for now. And Trump has separately targeted Brazil over the trial of his right-wing ally, former president Jair Bolsonaro, who is accused of planning a coup. US tariffs on various Brazilian goods surged from 10 percent to 50 percent Wednesday, but broad exemptions including for orange juice and civil aircraft are seen as softening the blow. Still, key products like Brazilian coffee, beef and sugar are hit. Many of Trump's sweeping tariffs face legal challenges over his use of emergency economic powers, with the cases likely to ultimately reach the US Supreme Court.
Iraqi News
06-08-2025
- Iraqi News
Ozempic maker Novo Nordisk posts strong results but competition weighs
Copenhagen – Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition is weighing on sales of its diabetes and obesity treatments Ozempic and Wegovy in the United States. The group reported a net profit of 26.5 billion kroner ($4.1 billion), a 32 percent increase from the same period last year, while sales increased by 18 percent to 76 billion kroner. The drug maker lowered its annual earnings outlook last week, causing its share price to continue its nearly year-long slide. The company had already cut its forecast in May and announced the departure of its chief executive Lars Fruergaard Jorgensen. 'In May we mostly thought the bottom was reached,' Mikael Bak, director of the Danish shareholders' association, told AFP. Bak said 'every is a bit surprised' that the situation has deteriorated. 'So now we don't want to see more disappointments, there are reasons to believe the business is healthy, the institution and the products good,' he said. Novo Nordisk announced last week that it was promoting Maziar Mike Doustdar, its vice president for international operations, to succeed Jorgensen. The popularity of Novo Nordisk's weight-loss treatments had once made it a darling of investors, boosting its share price and at one point making it Europe's most valuable company. But it now faces growing competition from rival treatments made by US group Eli Lilly in United States. A rule by the US Food and Drug Administration allowing pharmacies to create so-called 'compound' copycat versions of the drug, after high demand led to shortages, has also dented Novo Nordisk's earnings.
